1. NIH National Cancer Institute awards top-tier comprehensive status to UT Southwestern’s Harold C. Simmons Comprehensive Cancer

    01:35

    from UT Southwestern Added 23 0 0

    The National Cancer Institute (NCI) has awarded UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center its highest designation, making it one of only 45 cancer centers nationally to receive this distinction over the past 44 years.

    + More details
    • Meat Additives to Diminish Toxicity

      01:02

      from NutritionFacts Added

      For links to all the cited sources, a written transcript, commentary from Dr. Greger, as well as discussion and Q&A about this video, go to: http://nutritionfacts.org/video/meat-additives-to-diminish-toxicity/

      + More details
      • Asian Heritage Awards 2014 FLOSSIE WONG-STAAL

        04:35

        from Rosalynn Carmen Added

        Dr. Flossie Wong-Staal- In Her Own Words: “You need to have a passion for making discoveries because this is the most rewarding aspect of a scientific career. Eureka moments are few and far between. It’s important to go into a research lab, both to get some experience with the scientific process and see the kind of work that’s required. It’s also helpful to expose yourself to the passion and enthusiasm of outstanding scientists. In this way, you can get a glimpse of the dedication that science requires and also the satisfaction it can provide.” Dr. Flossie Wong-Staal, a molecular biologist and virologist, is one of the world’s authorities on the human immunodeficiency virus (HIV) and the first scientist to clone and to genetically map the virus. Born in China, Dr. Wong-Staal grew up in Hong Kong where she and her family fled in 1952 to escape communist Chinese rule. In Hong Kong, she attended an all-girls Catholic school where she excelled academically and was motivated by teachers toward science. After immigrating to the United States in 1965, Dr. Wong-Staal earned her B.A. degree in bacteriology and Ph.D. in molecular biology from UCLA. In 1972, she began postdoctoral research at UCSD until 1974 when she left to work with Robert Gallo at the National Cancer Institute. At the institute, Dr. Wong-Staal began her examination of retroviruses, and it was during this time of research that she cloned the HIV virus. In 1990, the Institute for Scientific Information recognized Dr. Wong-Staal as the top woman scientist of the previous decade. That same year, she returned to UCSD to continue her AIDS research. Four years later, the university created a new Center for AIDS Research with Dr. Wong-Staal as its chairman. In 2002, Dr. Wong-Staal retired from UCSD and now holds the title of Professor Emerita. In addition, she is co-founder and Chief Scientific Officer of iTherX where she researches treatments for Hepatitis C.

        + More details
        • New Research in Follicular Lymphoma

          11:05

          from Patient Power Added 33 0 0

          Where are we now with treatment options for follicular lymphoma? What can we expect in the near future? How are monoclonal antibodies changing therapy today? In this video, Dr. Wyndham Wilson (National Cancer Institute, Maryland, USA) joins Prof. John Gribben (Barts Cancer Institute, London, UK), at the 2014 International Workshop on Non-Hodgkin Lymphoma, where experts from the field discussed and debated the state of lymphoma research.

          + More details
          • Update: Watch and Wait or Continuous Therapy for Follicular Lymphoma

            06:15

            from Patient Power Added 10 1 0

            Newly-approved treatments are beginning to offer patients with follicular lymphoma new options for continuous disease control, while avoiding some of the side effects of traditional chemotherapy treatments. The question for many patients is whether or not these drugs might extend their lives longer than the traditional approach of watching and waiting to disease progression and treating only after the tumor has grown. Dr. Wyndham Wilson (National Cancer Institute, Maryland, USA) joins Dr. John Gribben (Barts Cancer Institute, London, UK) at the 2014 International Workshop on Non-Hodgkin Lymphoma to discuss these issues and their perspectives for patients today.

            + More details
            • The Signs and Symptoms of Follicular Lymphoma

              01:20

              from Patient Power Added 217 0 0

              How can you tell if you have follicular lymphoma, a common type of indolent non-Hodgkin lymphoma? Learn about the signs and symptoms from Dr. Wyndham Wilson (National Cancer Institute, Maryland, USA).

              + More details
              • SHARE Webinar: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer Institute with Dr. Patricia Steeg

                01:00:32

                from SHARE Added 213 0 0

                Patricia Steeg, PhD, Chief of Women's Cancers Section at the Center for Cancer Research at NCI, presents her novel research relating to metastatic breast cancer, including the development of experimental models of brain metastasis.

                + More details
                • Hospitals Selling Sickness

                  02:16

                  from NutritionFacts Added

                  For links to all the cited sources, a written transcript, commentary from Dr. Greger, as well as discussion and Q&A about this video, go to: http://nutritionfacts.org/video/hospitals-selling-sickness

                  + More details
                  • Learn the Signs and Symptoms of Follicular Lymphoma (FL)

                    02:15

                    from Patient Power Added 73 0 0

                    How can you tell if you might have Follicular Lymphoma (FL), a common type of indolent non-Hodgkin lymphoma (NHL). Learn the signs and symptoms from Dr. Wyndham Wilson from the National Cancer Institute (NCI).

                    + More details
                    • Watch and Wait or Continuous Therapy for Follicular Lymphoma: Where Are We Now?

                      07:21

                      from Patient Power Added 111 0 0

                      Newly approved medications are beginning to offer patients with indolent lymphomas new options for continuous disease control, while avoiding some of the side effects of traditional chemotherapy treatments. The question for many patients is whether or not these drugs might extend their lives longer than the traditional approach of watching and waiting to disease progression and treating only after the tumor has gotten larger. Dr. Wyndham Wilson from the National Cancer Institute joins Dr. John Gribben from Barts Cancer Center in London at the 2014 International Workshop on Non-Hodgkin Lymphoma to discuss these issues and their perspective for patients today.

                      + More details

                      What are Tags?

                      Tags

                      Tags are keywords that describe videos. For example, a video of your Hawaiian vacation might be tagged with "Hawaii," "beach," "surfing," and "sunburn."